Related Experiment Video

Updated: Oct 13, 2025

Bioluminescent Monitoring of Graft Survival in an Adoptive Transfer Model of Autoimmune Diabetes in Mice
10:03

Bioluminescent Monitoring of Graft Survival in an Adoptive Transfer Model of Autoimmune Diabetes in Mice

Published on: November 18, 2022

1.9K

Lumasiran, an RNAi Therapeutic for Primary Hyperoxaluria Type 1. Reply

Sander F Garrelfs1, John M Gansner2, John C Lieske3

  • 1Emma Children's Hospital, Amsterdam, the Netherlands s.f.garrelfs@amsterdamumc.nl.

The New England Journal of Medicine
|November 10, 2021
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Murine Bioluminescent Hepatic Tumour Model05:23

Murine Bioluminescent Hepatic Tumour Model

Published on: July 17, 2010

17.4K
In Vivo Imaging of Reactive Oxygen Species in a Murine Wound Model06:40

In Vivo Imaging of Reactive Oxygen Species in a Murine Wound Model

Published on: November 17, 2018

11.2K

Related Concept Videos

Nephrotic Syndrome III : Nursing Management01:24

Nephrotic Syndrome III : Nursing Management

Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
63